Trending...
- Boston: Mayor Walsh recommends 67 projects, totaling over $25.5 million in funding through Community Preservation Act
- City of Boston annual healthcare enrollment 2021
- Thru-hikers Launch New Nature Streaming TV Channel for Nature Lovers
MARLBOROUGH, Mass., Feb. 12, 2021 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will participate in two upcoming investor conferences.
On February 25, 2021, Dan Brennan, executive vice president and chief financial officer, and Susie Lisa, vice president, Investor Relations, will participate in a 30-minute question-and-answer session with the host analyst at the virtual SVB Leerink 10th Annual Global Healthcare Conference. The session will begin at approximately 10:40 a.m. EST.
On March 1, 2021, Meghan Scanlon, senior vice president and president, Urology and Pelvic Health, and Susie Lisa will participate in a 30-minute question-and-answer session with the host analyst at the virtual Cowen 41st Annual Health Care Conference. The session will begin at approximately 2 p.m. EST.
A live webcast and replay of the webcast for each event will be accessible at investors.bostonscientific.comhttp://www.bostonscientific.com/investors. The replay will be available beginning approximately one hour following the completion of each event.
More on Boston Chron
About Boston Scientific
Boston Scientific transforms lives through innovative medical solutions that improve the health of patients around the world. As a global medical technology leader for 40 years, we advance science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce the cost of healthcare. For more information, visit www.bostonscientific.com and connect on Twitter and Facebook.
SOURCE Boston Scientific Corporation
More on Boston Chron
Related Links
http://www.bostonscientific.com
On February 25, 2021, Dan Brennan, executive vice president and chief financial officer, and Susie Lisa, vice president, Investor Relations, will participate in a 30-minute question-and-answer session with the host analyst at the virtual SVB Leerink 10th Annual Global Healthcare Conference. The session will begin at approximately 10:40 a.m. EST.
On March 1, 2021, Meghan Scanlon, senior vice president and president, Urology and Pelvic Health, and Susie Lisa will participate in a 30-minute question-and-answer session with the host analyst at the virtual Cowen 41st Annual Health Care Conference. The session will begin at approximately 2 p.m. EST.
A live webcast and replay of the webcast for each event will be accessible at investors.bostonscientific.comhttp://www.bostonscientific.com/investors. The replay will be available beginning approximately one hour following the completion of each event.
More on Boston Chron
- Boston Parks and Recreation Commission ratifies Roberts Playground naming
- Boston: Demolition Delay application: 50 Landseer Street, West Roxbury
- Boston: Mayor's Cup Street Hockey Tournament starts April 20
- Analog Devices to Participate in Raymond James Institutional Investors Conference
- First- Time $50,000 Grant Received
About Boston Scientific
Boston Scientific transforms lives through innovative medical solutions that improve the health of patients around the world. As a global medical technology leader for 40 years, we advance science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce the cost of healthcare. For more information, visit www.bostonscientific.com and connect on Twitter and Facebook.
CONTACTS | |
Media: | Investors: |
Katie Schur | Susie Lisa, CFA |
508-683-5574 (office) | 508-683-5565 (office) |
Media Relations | Investor Relations |
Boston Scientific Corporation | Boston Scientific Corporation |
[email protected] | [email protected] |
SOURCE Boston Scientific Corporation
More on Boston Chron
- Pastor Tracy S. Williams Talks Sex and Relationships in Her Debut Book: THE GARDEN EXPERIENCE AN ABSTINENCE HANDBOOK FOR GIRLS
- Boston: Design decisions: Revamping the Parks homepage
- Boston will enter modified version of Phase 3, Step 2 of the state's reopening plan on Monday
- Sugaring: The Green Juice of Hair Removal
- Tekla Healthcare Opportunities Fund Paid Distribution
Related Links
http://www.bostonscientific.com
Filed Under: Business
0 Comments
Latest on Boston Chron
- Thru-hikers Launch New Nature Streaming TV Channel for Nature Lovers
- American Tower Corporation to Present at the Raymond James 42nd Annual Institutional Investors Conference
- Changes to City of Boston Non-Medicare health plans
- Bronx DWI Lawyer Announces New Website
- Recording Artist "Cherne" Crystal Brown auditions for Sony Music, Atlantic Records and Capitol Records and it doesn't stop there
- Massachusetts: Baker-Polito Administration Announces $4.7 Million for Vaccine Equity in Hardest-Hit Communities; Regional Vaccination Collaboratives
- Boston: Moving to the new BCBSMA HMO plan
- Honorary Oscar-Winner Charles Burnett brings his award winning film on COVID-19 / Black Hollywood to the Prestigious Pan African 2021 Film Festival
- Black history is Boston history
- In a year of recession, Lantek closes 2020 with record sales figures and customer numbers
- Allego Announces Record-Breaking Q4 and Full Year of Customer and Revenue Growth Marked by Product Innovation and Continued Market Leadership
- Alzheon CEO Presents Overview of Oral Anti-Amyloid ALZ-801 Phase 3 Program at 9th Neurodegenerative Drug Development Summit
- The Koedo Kawagoe Spring Festival Celebrates the Arrival of Springtime in Kawagoe, Japan
- Aaron's Energy: An Unexpected Journey Through Grief and the Afterlife With My Brilliant Son
- Boston: Two easy ways to get involved with climate-ready planning
- Libman Education Introduces Coding Workspace™ Next Generation Coder Training
- MC Residential Activates in the Wake of Texas Weather Crisis
- The Best SEO Company in New York City Is Proving Local Businesses Free SEO Audit As COVID-19 Relief
- Gutenberg Technology Wins 2021 BIG Innovation Award
- Boston Arts Academy marks major milestone in construction of new $125 million facility in Fenway